Status: Recruiting
Sonlicromanol in Post-COVID
The aim of this randomized, double-blind, placebo-controlled, phase II trial, is to study the effect of sonlicromanol on fatigue in patients with post-COVID who experience post-exertional malaise (PEM).
Participants needed: 80
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Michele van VugtUpdated: Apr 13, 2026Locations: 1
Eligibility criteria
Post COVID according to WHO criteria and verified by post COVID physician [+4]
Patients at risk for cardiac conduction disorders [+14]